The use of mouse CD96 antibodies is shown to significantly inhibit the growth of colorectal cancer, melanoma, and subcutaneous fibrosarcoma in mice, a mechanism independent of NK cells and requires the involvement of CD8+ T cells and IFN-γ [28]. This evidence concerns the gene CD8A and fibrosarcoma.